TCL Archive FDA Committee Okays Leuprolide NDA, But Recommends Against Mitoxantrne, Epirubicin April 5, 1985
TCL Archive NCI Program Review: Report calls For Two Types Of Centers: Comprehensive And All Others October 18, 1996
TCL Archive Abraxane Combination Improves Survival In Treatment-Naïve Metastatic Disease February 22, 2013